Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.

Au-Yeung SK. et al, (2022), Evid Based Ment Health, 25, 77 - 83

Patient perspectives of lithium and quetiapine augmentation treatment in treatment-resistant depression: A qualitative assessment.

McKeown L. et al, (2022), J Psychopharmacol

Joint patient and clinician priority setting to identify 10 key research questions regarding the long-term sequelae of COVID-19.

Houchen-Wolloff L. et al, (2022), Thorax

Clinical- and cost-effectiveness of a technology-supported and solution-focused intervention (DIALOG+) in treatment of patients with chronic depression-study protocol for a multi-site, cluster randomised controlled trial [TACK].

McNamee P. et al, (2022), Trials, 23

Association between serum lithium level and incidence of COVID-19 infection.

De Picker LJ. et al, (2022), Br J Psychiatry, 1 - 3

Mental health prior to and during the COVID-19 pandemic in individuals with bipolar disorder: Insights from prospective longitudinal data.

Lewis KJS. et al, (2022), Bipolar Disord

Commercial Use of Emotion Artificial Intelligence (AI): Implications for Psychiatry.

Monteith S. et al, (2022), Curr Psychiatry Rep, 24, 203 - 211

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: Systematic review, meta-analysis, and rationale.

Hong JSW. et al, (2022), Mol Psychiatry, 27, 1339 - 1349

Association of Schizophrenia Spectrum Disorders and Violence Perpetration in Adults and Adolescents From 15 Countries: A Systematic Review and Meta-analysis.

Whiting D. et al, (2022), JAMA Psychiatry, 79, 120 - 132

Pharmacological treatment for psychotic depression.

Kruizinga J. et al, (2021), Cochrane Database Syst Rev, 12

Use of online cultural content for mental health and well-being during COVID-19 restrictions: cross-sectional survey.

Syed Sheriff RJ. et al, (2021), BJPsych Bull, 1 - 10

Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder.

Dean RL. et al, (2021), Cochrane Database Syst Rev, 10

The costs of bipolar disorder in the United Kingdom.

Simon J. et al, (2021), Brain Behav, 11

Impact of COVID-19 on telepsychiatry at the service and individual patient level across two UK NHS mental health Trusts.

Hong JS. et al, (2021), Evid Based Ment Health

Cerebral venous thrombosis and portal vein thrombosis: A retrospective cohort study of 537,913 COVID-19 cases.

Taquet M. et al, (2021), EClinicalMedicine, 39

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.

Taquet M. et al, (2021), PLoS Med, 18

Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study.

Bogowicz P. et al, (2021), BJGP Open, 5

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Sen A. et al, (2021), Trials, 22

Incidence and outcomes of eating disorders during the COVID-19 pandemic.

HARRISON P. et al, (2021), British Journal of Psychiatry

Neuropsychiatric disorders and COVID-19 - Authors' reply.

Taquet M. et al, (2021), Lancet Psychiatry, 8, 565 - 566

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?